よむ、つかう、まなぶ。
【資料No.1】1.12_添付資料一覧 (18 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_29325.html |
| 出典情報 | 薬事・食品衛生審議会 薬事分科会（令和4年度第5回 11／22）、医薬品第二部会（令和4年度第13回 11／22）（合同開催）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
S-217622
1.12
4.3-28
Dietary Deprivation
Induces Fetal Loss
and Abortion in
Rabbits
Matsuzawa T,
Nakata M, Goto
I, Tsushima M
海外
Toxicology
1981;22:255-9
2.4-28
2.6.625
4.3-29
HDL and Reverse
Cholesterol
Transport
Ouimet M,
Barrett TJ,
Fisher EA
海外
Circ Res
2019;124:1505-18
2.4-29
2.6.6-7
4.3-30
The plasma
lecithins:cholestero
Glomset JA
l acyltransferase
reaction
海外
J Lipid Res
1968;9(2):155-67
2.4-30
2.6.608
4.3-31
HDL-Replacement
Therapy: Mechanism
Remaley AT, Amar
of Action, Types of
M, Sviridov D
Agents and Potential
Clinical Indications
海外
Expert Rev
Cardiovasc Ther
2008;6(9):1203-15
2.4-31
2.6.609
4.3-32
Lecithin:Cholesterol
Acyltransferase:
From Biochemistry to
Role in
Cardiovascular
Disease
Rousset X,
Vaisman B, Amar
M, Sethi AA,
Remaley AT
海外
Curr Opin
Endocrinol
Diabetes Obes
2009;16(2):163-71
2.4-32
2.6.610
4.3-33
The Macrophage and
Its Related
Cholesterol Efflux
as A HDL Function
Index in
Atherosclerosis
Yamamoto S,
Narita I, Kotani
K
海外
Clin Chim Acta
2016;457:117-22
2.4-33
2.6.611
4.3-34
Serum Cholesterol
and Triglyceride
Reference Ranges of
Furusyo N, Ai M,
Twenty Lipoprotein
Okazaki M, et al
Subclasses for
Healthy Japanese Men
and Women
海外
Atherosclerosis
2013;231: 238-45
2.4-34
2.6.627
Barter PJ,
Brewer HB,
Chapman MJ, et
al
海外
Arterioscler
Thromb Vasc Biol
2003;23:160-7
2.4-35
2.6.628
Chou TC, Talalay
P
海外
Adv Enzyme Regul
1984;22:27-55
2.6.201
4.3-37
A rapid
mitochondrial
Sanuki Y, Araki
toxicity assay
T, Nakazono O,
utilizing rapidly
Tsurui K
changing cell energy
metabolism
海外
J Toxicol Sci
2017;423(3):34958
2.6.202
4.3-38
Decreased
gluconeogenesis and
increased glucose
Goto M, Zeller
disposal without
WP, Lichtenberg
hyperinsulinemia in RC
10-day-old rats with
endotoxic shock
海外
Metabolism
1994;43:1248-54
2.6.602
4.3-35
4.3-36
Cholesteryl Ester
Transfer Protein: A
Novel Target for
Raising HDL and
Inhibiting
Atherosclerosis
Quantitative
analysis of doseeffect
relationships: the
combined effects of
multiple drugs or
enzyme inhibitors
4.2-18
添付資料一覧
1.12
4.3-28
Dietary Deprivation
Induces Fetal Loss
and Abortion in
Rabbits
Matsuzawa T,
Nakata M, Goto
I, Tsushima M
海外
Toxicology
1981;22:255-9
2.4-28
2.6.625
4.3-29
HDL and Reverse
Cholesterol
Transport
Ouimet M,
Barrett TJ,
Fisher EA
海外
Circ Res
2019;124:1505-18
2.4-29
2.6.6-7
4.3-30
The plasma
lecithins:cholestero
Glomset JA
l acyltransferase
reaction
海外
J Lipid Res
1968;9(2):155-67
2.4-30
2.6.608
4.3-31
HDL-Replacement
Therapy: Mechanism
Remaley AT, Amar
of Action, Types of
M, Sviridov D
Agents and Potential
Clinical Indications
海外
Expert Rev
Cardiovasc Ther
2008;6(9):1203-15
2.4-31
2.6.609
4.3-32
Lecithin:Cholesterol
Acyltransferase:
From Biochemistry to
Role in
Cardiovascular
Disease
Rousset X,
Vaisman B, Amar
M, Sethi AA,
Remaley AT
海外
Curr Opin
Endocrinol
Diabetes Obes
2009;16(2):163-71
2.4-32
2.6.610
4.3-33
The Macrophage and
Its Related
Cholesterol Efflux
as A HDL Function
Index in
Atherosclerosis
Yamamoto S,
Narita I, Kotani
K
海外
Clin Chim Acta
2016;457:117-22
2.4-33
2.6.611
4.3-34
Serum Cholesterol
and Triglyceride
Reference Ranges of
Furusyo N, Ai M,
Twenty Lipoprotein
Okazaki M, et al
Subclasses for
Healthy Japanese Men
and Women
海外
Atherosclerosis
2013;231: 238-45
2.4-34
2.6.627
Barter PJ,
Brewer HB,
Chapman MJ, et
al
海外
Arterioscler
Thromb Vasc Biol
2003;23:160-7
2.4-35
2.6.628
Chou TC, Talalay
P
海外
Adv Enzyme Regul
1984;22:27-55
2.6.201
4.3-37
A rapid
mitochondrial
Sanuki Y, Araki
toxicity assay
T, Nakazono O,
utilizing rapidly
Tsurui K
changing cell energy
metabolism
海外
J Toxicol Sci
2017;423(3):34958
2.6.202
4.3-38
Decreased
gluconeogenesis and
increased glucose
Goto M, Zeller
disposal without
WP, Lichtenberg
hyperinsulinemia in RC
10-day-old rats with
endotoxic shock
海外
Metabolism
1994;43:1248-54
2.6.602
4.3-35
4.3-36
Cholesteryl Ester
Transfer Protein: A
Novel Target for
Raising HDL and
Inhibiting
Atherosclerosis
Quantitative
analysis of doseeffect
relationships: the
combined effects of
multiple drugs or
enzyme inhibitors
4.2-18
添付資料一覧